Lambert Potin

7PUBLICATIONS
30CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyInnate immunityCancer therapy (excl. chemotherapy and radiation therapy)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 24, 2023
TGF-β Signaling Prevents MHC Class II-Expressing Lymphatic Endothelial Cells from Reactivating Human Allogenic Memory CD4+ T Cells.

Renata Mezyk-Kopec, Lambert Potin, J Emiliano Gomez Medellin

|Apr 15, 2020
Collagen-binding IL-12 enhances tumour inflammation and drives the complete remission of established immunologically cold mouse tumours.

Aslan Mansurov, Jun Ishihara, Peyman Hosseinchi

|Apr 12, 2019
Targeted antibody and cytokine cancer immunotherapies through collagen affinity.

Jun Ishihara, Ako Ishihara, Koichi Sasaki

|Aug 12, 2018
Improving Efficacy and Safety of Agonistic Anti-CD40 Antibody Through Extracellular Matrix Affinity.

Jun Ishihara, Ako Ishihara, Lambert Potin

|Nov 10, 2017
Matrix-binding checkpoint immunotherapies enhance antitumor efficacy and reduce adverse events.

Jun Ishihara, Kazuto Fukunaga, Ako Ishihara

Pageof 2